These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17437644)

  • 1. The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits.
    Chan WF; Perez-Diez A; Razavy H; Anderson CC
    Biol Direct; 2007 Apr; 2():10. PubMed ID: 17437644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation.
    Kim N; Lee H; Shin J; Nam YS; Im KI; Lim JY; Lee ES; Kang YN; Park SH; Cho SG
    PLoS One; 2015; 10(5):e0126318. PubMed ID: 25961559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and long-lasting peripheral chimerism after allogeneic intestinal transplantation in MGH miniature swine.
    Ishikawa Y; Hirakata A; Griesemer AD; Etter J; Moran S; Weiner J; Shimizu A; Yamada K
    Transplantation; 2010 Feb; 89(4):417-26. PubMed ID: 20177343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction by costimulator blockade in 100 cGy treated hosts with varying degrees of genetic disparity.
    Abedi M; Greer D; Lambert JF; Colvin GA; Dooner MS; McAuliffe CI; Demers D; Moore BE; Quesenberry PJ
    Leukemia; 2003 Sep; 17(9):1871-9. PubMed ID: 12970789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-myeloablative mixed chimerism approaches and tolerance, a split decision.
    Luo B; Chan WF; Shapiro AM; Anderson CC
    Eur J Immunol; 2007 May; 37(5):1233-42. PubMed ID: 17390394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passenger lymphocyte syndrome in ABO and Rhesus D minor mismatched liver and kidney transplantation: A prospective analysis.
    ElAnsary M; Hanna MO; Saadi G; ElShazly M; Fadel FI; Ahmed HA; Aziz AM; ElSharnouby A; Kandeel MM
    Hum Immunol; 2015 Jun; 76(6):447-52. PubMed ID: 25842056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.
    Shirasugi N; Emmanouilidis N; Pearson TC; Larsen CP
    Transplant Proc; 2004 Oct; 36(8):2423-4. PubMed ID: 15561267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New trends in immunosuppressive therapy in patients with kidney transplants].
    Savić M; Petrović V
    Srp Arh Celok Lek; 1997; 125(3-4):99-105. PubMed ID: 9221526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.